INN:

Inotuzumab ozogamicin View all treatment options

Class:

CD22 MAb ADC

Adapted from Thomas X. Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia. Blood and lymphatic cancer: targets and therapy. April 2014; 4: 1-8. doi: 10.2147/BLCTT.S49048

All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the Lymphoma Coalition.